Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 10/20 | 0.34 |
| ▸ | NUAK2 | Q9H093 | 2/20 | 0.34 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.34 |
| ▸ | CTSC | P53634 | 2/20 | 0.33 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.33 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | BLK | P51451 | 1/20 | 0.31 |
| ▸ | BMX | P51813 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24310094 | 0.90 | CTSC (0.39) | EGFRNUAK2CTSCIGF1RNUAK1 | |
| SCHEMBL24310068 | 0.87 | EGFR (0.35) | EGFRNUAK2CTSCIGF1RNUAK1 | |
| SCHEMBL24310776 | 0.85 | CTSC (0.37) | EGFRNUAK2CTSCIGF1RNUAK1 | |
| SCHEMBL29567082 | 0.84 | HTR2C (0.39) | EGFRNUAK2DCTPP1IGF1RNUAK1 | |
| SCHEMBL24310802 | 0.84 | IGF1R (0.31) | IGF1RMAP4K1 | |
| SCHEMBL24309586 | 0.84 | HTR2C (0.39) | EGFRNUAK2DCTPP1IGF1RNUAK1 | |
| SCHEMBL24310543 | 0.82 | MAP4K1 (0.39) | EGFRIGF1RHRH4BRD4MAP4K1 | |
| SCHEMBL24310071 | 0.79 | LCK (0.35) | EGFRIGF1RTNK2JAK3 | |
| SCHEMBL24310186 | 0.78 | CTSC (0.35) | EGFRCTSCIGF1RHRH4MAP4K1 | |
| SCHEMBL26811481 | 0.78 | HTR2C (0.40) | EGFRNUAK2CTSCNUAK1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |